Skip to main content

Preliminary IND-enalbing Studies of OP449 as a Novel Cancer Therapeutic

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
May 14, 2013
Award amount: 
$250,000
Organization name: 
Oncotide Pharmaceuticals
Principal Investigator: 
Christensen, Dale J.
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

Oncotide Pharmaceuticals has developed a novel cancer therapeutic and will prepare GMP drug and perform the preclinical studies that are the foundation for preparation of a full Investigational New Drug application for the FDA to start human clinical trials.

Fiscal year: 
2013